Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice
- 28 April 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 343 (1) , 269-278
- https://doi.org/10.1016/j.bbrc.2006.02.142
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4+ T cells and CD8+ T cellsCancer Science, 2005
- Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell–Mediated Tumor Rejection without Autoimmune Reactions in MiceClinical Cancer Research, 2004
- Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA‐A*0201‐restricted epitopesInternational Journal of Cancer, 2003
- Generation and genetic modification of dendritic cells derived from mouse embryonic stem cellsBlood, 2003
- Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune ResponsesAnnual Review of Immunology, 2002
- The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptorEuropean Journal of Immunology, 2000
- Modulation of the Chaperone Activities of Hsc70/Hsp40 by Hsp105α and Hsp105βBiochemical and Biophysical Research Communications, 2000
- HEAT-SHOCK PROTEINS, MOLECULAR CHAPERONES, AND THE STRESS RESPONSE: Evolutionary and Ecological PhysiologyAnnual Review of Physiology, 1999
- Dendritic Cell Vaccines for Cancer ImmunotherapyAnnual Review of Medicine, 1999
- Cloning and Expression of Murine High Molecular Mass Heat Shock Proteins, HSP105Journal of Biological Chemistry, 1995